Objective. To determine whether antihypertensive therapy reduces the risk of stroke among elderly patients with hy-pertension. Design. Multicenter, randomized, double-blind, placebo-controlled trial. Setting and participants. 3845 patients aged ≥ 80 years from 195 centers in 13 countries with sustained systolic blood pressure ≥ 160 mm Hg at enrollment. Patients with accelerated or sec-ondary hypertension, recent hemorrhagic stroke, existing heart failure, serum creatinine> 1.7 mg/dL, hypo- or hyperkalemia, gout, dementia, nursing home care, or a contraindication to a study medication were excluded. Patients were randomized to either a daily diuretic (sustained-release indapamide, 1.5 mg; n = 1933) or placebo (n = 1912). If the target blo...
SummaryBackgroundObservational epidemiological studies have shown a positive association between hyp...
OBJECTIVE To assess if very elderly people with hypertension obtain early benefit from antihypert...
ObjectivesThe aim of this study was to test the hypothesis that the angiotensin II type 1 receptor b...
BACKGROUND: Whether the treatment of patients with hypertension who are 80 years of age or older is ...
Importance: Deprescribing of antihypertensive medications is recommended for some older patients wit...
BACKGROUND: The results of the Hypertension in the Very Elderly Trial showed positive benefits from ...
OBJECTIVE: To assess if very elderly people with hypertension obtain early benefit from antihyperten...
Importance: Deprescribing of antihypertensive medications is recommended for some older patients wit...
Contains fulltext : 69201.pdf (publisher's version ) (Closed access)The 'Hypertens...
Importance: Deprescribing of antihypertensive medications is recommended for some older patients wit...
A number of trials and meta-analyses have demonstrated clear benefits of blood pressure (BP) reducti...
BACKGROUND: Observational epidemiological studies have shown a positive association between hyperten...
Objective To assess if very elderly people with hypertension obtain early benefit from antihypertens...
Introduction: Recent evidence suggests that larger blood pressure reductions and multiple antihypert...
Background: Treatment for hypertension with antihypertensive medication has been shown to reduce str...
SummaryBackgroundObservational epidemiological studies have shown a positive association between hyp...
OBJECTIVE To assess if very elderly people with hypertension obtain early benefit from antihypert...
ObjectivesThe aim of this study was to test the hypothesis that the angiotensin II type 1 receptor b...
BACKGROUND: Whether the treatment of patients with hypertension who are 80 years of age or older is ...
Importance: Deprescribing of antihypertensive medications is recommended for some older patients wit...
BACKGROUND: The results of the Hypertension in the Very Elderly Trial showed positive benefits from ...
OBJECTIVE: To assess if very elderly people with hypertension obtain early benefit from antihyperten...
Importance: Deprescribing of antihypertensive medications is recommended for some older patients wit...
Contains fulltext : 69201.pdf (publisher's version ) (Closed access)The 'Hypertens...
Importance: Deprescribing of antihypertensive medications is recommended for some older patients wit...
A number of trials and meta-analyses have demonstrated clear benefits of blood pressure (BP) reducti...
BACKGROUND: Observational epidemiological studies have shown a positive association between hyperten...
Objective To assess if very elderly people with hypertension obtain early benefit from antihypertens...
Introduction: Recent evidence suggests that larger blood pressure reductions and multiple antihypert...
Background: Treatment for hypertension with antihypertensive medication has been shown to reduce str...
SummaryBackgroundObservational epidemiological studies have shown a positive association between hyp...
OBJECTIVE To assess if very elderly people with hypertension obtain early benefit from antihypert...
ObjectivesThe aim of this study was to test the hypothesis that the angiotensin II type 1 receptor b...